Salmonellosis risk factors: Difference between revisions

Jump to navigation Jump to search
m (Changes made per Mahshid's request)
 
(6 intermediate revisions by one other user not shown)
Line 4: Line 4:


==Overview==
==Overview==
[[Risk factor]]s for [[salmonellosis]] are all those that expose the person to the [[Salmonella|bacteria]], and that create an adequate environment for [[infection]], such as: low [[gastric]] [[pH]]; changes in [[intestinal flora]]; [[malignancy]]; [[diabetes]]; and [[immunosuppressive]] therapies.  [[Risk factor]]s for the persistence of [[infection]] with [[Salmonella]], include locals of anatomic disruptions, such as: [[gallstones]]; [[kidney stones]]; and [[atherosclerotic plaque]].<ref name="pmid11170916">{{cite journal| author=Hohmann EL| title=Nontyphoidal salmonellosis. | journal=Clin Infect Dis | year= 2001 | volume= 32 | issue= 2 | pages= 263-9 | pmid=11170916 | doi=10.1086/318457 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11170916  }} </ref><ref name="pmid14702426">{{cite journal| author=Thielman NM, Guerrant RL| title=Clinical practice. Acute infectious diarrhea. | journal=N Engl J Med | year= 2004 | volume= 350 | issue= 1 | pages= 38-47 | pmid=14702426 | doi=10.1056/NEJMcp031534 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14702426  }} </ref>


==Risk Factors==
==Risk Factors==
Affects all age groups. Groups at greatest risk for severe or complicated disease include infants, the elderly, and persons with compromised [[immune system]]s.
Affects all age groups. Groups at greatest risk for severe or complicated disease include infants, the elderly, and persons with compromised [[immune system]]s.


[[Risk factor]]s for [[salmonellosis]] include all factors that expose the person to the [[bacteria]], and that create an adequate environment for the [[infection]].<ref name="pmid11170916">{{cite journal| author=Hohmann EL| title=Nontyphoidal salmonellosis. | journal=Clin Infect Dis | year= 2001 | volume= 32 | issue= 2 | pages= 263-9 | pmid=11170916 | doi=10.1086/318457 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11170916  }} </ref> These factors include diseases and treatments that affect some of the body's defense mechanisms, including:
[[Risk factor]]s for [[salmonellosis]] are all those that expose the person to the [[bacteria]], and that create an adequate environment for [[infection]].<ref name="pmid11170916">{{cite journal| author=Hohmann EL| title=Nontyphoidal salmonellosis. | journal=Clin Infect Dis | year= 2001 | volume= 32 | issue= 2 | pages= 263-9 | pmid=11170916 | doi=10.1086/318457 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11170916  }} </ref> All these factors affect somehow, one or more of the defense mechanisms of the body, and may include:<ref name="pmid11170916">{{cite journal| author=Hohmann EL| title=Nontyphoidal salmonellosis. | journal=Clin Infect Dis | year= 2001 | volume= 32 | issue= 2 | pages= 263-9 | pmid=11170916 | doi=10.1086/318457 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11170916  }} </ref><ref name="pmid14702426">{{cite journal| author=Thielman NM, Guerrant RL| title=Clinical practice. Acute infectious diarrhea. | journal=N Engl J Med | year= 2004 | volume= 350 | issue= 1 | pages= 38-47 | pmid=14702426 | doi=10.1056/NEJMcp031534 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14702426  }} </ref>
*Low gastric pH in children
*Low [[gastric]] pH in children
*Low gastric pH from antacids and [[H2 antagonist]]s
*Low [[gastric]] pH from [[antacids]] and [[H2 antagonist]]s
*[[Pernicious anemia]]
*[[Pernicious anemia]]
*Changes in the normal endogenous [[intestinal]] flora, possibly caused by [[antibiotic]] treatments or surgery
*Changes in the normal endogenous [[intestinal flora]] (often caused by [[antibiotic]] treatments or surgery)
*[[Malignancy]]
*[[Malignancy]]
*[[Diabetes]]
*[[Diabetes]]
Line 19: Line 20:
*[[Immunosuppressive]] therapies
*[[Immunosuppressive]] therapies


[[Salmonella]] may persist in certain foci in the body, such as locals of anatomical disruptions. These may include:<ref name="pmid11170916">{{cite journal| author=Hohmann EL| title=Nontyphoidal salmonellosis. | journal=Clin Infect Dis | year= 2001 | volume= 32 | issue= 2 | pages= 263-9 | pmid=11170916 | doi=10.1086/318457 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11170916  }} </ref>
[[Salmonella]] may persist, in foci, in certain organs of the body, particularly locals with anatomical disruptions. These may include:<ref name="pmid11170916">{{cite journal| author=Hohmann EL| title=Nontyphoidal salmonellosis. | journal=Clin Infect Dis | year= 2001 | volume= 32 | issue= 2 | pages= 263-9 | pmid=11170916 | doi=10.1086/318457 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11170916  }} </ref>
*[[Gallstones]]
*[[Gallstones]]
*[[Kidney stones]]
*[[Kidney stones]]
Line 33: Line 34:
[[Category:Zoonoses]]
[[Category:Zoonoses]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Infectious disease]]
 
[[Category:Emergency medicine]]
[[Category:Emergency medicine]]
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]

Latest revision as of 18:41, 18 September 2017

Salmonellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Salmonellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Salmonellosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Salmonellosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Salmonellosis risk factors

CDC on Salmonellosis risk factors

Salmonellosis risk factors in the news

Blogs on Salmonellosis risk factors

Directions to Hospitals Treating Salmonellosis

Risk calculators and risk factors for Salmonellosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]

Overview

Risk factors for salmonellosis are all those that expose the person to the bacteria, and that create an adequate environment for infection, such as: low gastric pH; changes in intestinal flora; malignancy; diabetes; and immunosuppressive therapies. Risk factors for the persistence of infection with Salmonella, include locals of anatomic disruptions, such as: gallstones; kidney stones; and atherosclerotic plaque.[1][2]

Risk Factors

Affects all age groups. Groups at greatest risk for severe or complicated disease include infants, the elderly, and persons with compromised immune systems.

Risk factors for salmonellosis are all those that expose the person to the bacteria, and that create an adequate environment for infection.[1] All these factors affect somehow, one or more of the defense mechanisms of the body, and may include:[1][2]

Salmonella may persist, in foci, in certain organs of the body, particularly locals with anatomical disruptions. These may include:[1]

References

  1. 1.0 1.1 1.2 1.3 Hohmann EL (2001). "Nontyphoidal salmonellosis". Clin Infect Dis. 32 (2): 263–9. doi:10.1086/318457. PMID 11170916.
  2. 2.0 2.1 Thielman NM, Guerrant RL (2004). "Clinical practice. Acute infectious diarrhea". N Engl J Med. 350 (1): 38–47. doi:10.1056/NEJMcp031534. PMID 14702426.


Template:WikiDoc Sources

Template:WikiDoc Sources